Authors: Created 1997; Updated: Dr Sashika Samaranayaka, Post Graduate Year 1, Department of Dermatology, Middlemore Hospital, Auckland, New Zealand; Hon Assoc Prof Paul Jarrett, Dermatologist, Clinical Head Dermatology, Middlemore Hospital and Department of Medicine, The University of Auckland, Auckland, New Zealand. Copy edited by Gus Mitchell. July 2021
Applied to the face once daily at bedtime, topical retinoids such as adapalene, isotretinoin, tretinoin (retinoic acid), and trifarotene can help mild to moderately severe acne. They are effective first-line treatment for comedonal and inflammatory acne, but are not recommended as monotherapy for severe acne, especially if there are pustules with deep nodules and cysts. It may take 12 weeks or longer before improvement is seen.
Topical retinoids may reduce the severity of existing scarring and subsequent acne scarring.
Inflammatory dermatoses including acne vulgaris may resolve with postinflammatory hyperpigmentation particularly in skin of colour. Topical retinoids are useful to treat post-inflammatoryhyperpigmentation as they inhibitmelanosome transfer and facilitate melanin dispersal. They are particularly recommended for the treatment of acne in skin of colour.
Topical retinoids can be used to treat facial acne
Topical tretinoin may be combined with other active ingredients in skin bleaching cream to treat melasma.
Darier disease and others
Topical isotretinoin, tretinoin, and adapelene have been used for localisedDarier disease, reporting significant clinical improvement in symptoms. Topical retinoids may be used to treat many dermatoses - see the list of page links below (On DermNet).
Percutaneous absorption of topical retinoids is limited. However, women of childbearing age must use effective contraception due to the teratogenic effects of retinoids.
Topical retinoids are generally not recommended for use by young children - varies between countries and specific product
Dryness due to a topical retinoid
Dryness due to a topical retinoid
Tell me more about topical retinoids.
Retinoids act at a cellular level. They activate genes involved in the physiology of keratinocytes by binding to specific nuclear receptors, retinoic acid receptor (RAR) and retinoid X receptor (RXR).
Topical retinoids such as retinol and retinaldehyde are commonly added to cosmetics.
Prescribed topical retinoids include adapalene, alitretinoin, tazarotene, tretinoin, and trifarotene. They come in a variety of formulations. Gels are the least cosmetically noticeable; creams are the least irritating. Applying them at night (or just before sleep) mean they are less noticeable when treating the face. The regular application of a sunscreen/moisturiser combination during the day will protect against the sun sensitivity and dryness.
Retinoids can be classified as:
First generation
Isotretinoin, tretinoin, and alitretinoin are modifications of natural retinoids which do not act selectively
Teratogenic — potential risk in pregnancy particularly with widespread tazarotene use (pregnancy category X in US)
Approved datasheets are the official source of information for medicines, including approved uses, doses, and safety information. Check the individual datasheet in your country for information about medicines.
Cheng C, Michaels J, Scheinfeld N. Alitretinoin: a comprehensive review. Expert Opin Investig Drugs. 2008;17(3):437–43. doi:10.1517/13543784.17.3.437. PubMed
Cosio T, Di Prete M, Gaziano R, et al. Trifarotene: a current review and perspectives in dermatology. Biomedicines. 2021;9(3):237. doi:10.3390/biomedicines9030237. Journal
Kaplan YC, Ozsarfati J, Etwel F, Nickel C, Nulman I, Koren G. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis. Br J Dermatol. 2015;173(5):1132–41. doi:10.1111/bjd.14053. PubMed
Poon F, Kang S, Chien AL. Mechanisms and treatments of photoaging. Photodermatol Photoimmunol Photomed. 2015;31(2):65–74. doi:10.1111/phpp.12145. Journal
Querfeld C, Nagelli LV, Rosen ST, Kuzel TM, Guitart J. Bexarotene in the treatment of cutaneous T-cell lymphoma. Expert Opin Pharmacother. 2006;7(7):907–15. doi:10.1517/14656566.7.7.907. PubMed
Rusu A, Tanase C, Pascu GA, Todoran N. Recent advances regarding the therapeutic potential of adapalene. Pharmaceuticals (Basel). 2020;13(9):217. doi:10.3390/ph13090217. Journal
Talpur R, Cox K, Duvic M. Efficacy and safety of topical tazarotene: a review. Expert Opin Drug Metab Toxicol. 2009;5(2):195–210. doi:10.1517/17425250902721250. PubMed
Tan J, Tanghetti E, Baldwin H, Stein Gold L, Lain E. The role of topical retinoids in prevention and treatment of atrophic acne scarring: understanding the importance of early effective treatment. J Drugs Dermatol. 2019;18(3):255–60. PubMed
Zaenglein AL, Levy ML, Stefanko NS, et al. Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents. Pediatr Dermatol. 2021;38(1):164–80. doi:10.1111/pde.14408. Journal